Science says staying the course—a key ingredient for success—comes down to personal incentives.

Scientists have used artificial intelligence (AI) to create potential new drugs for so-called superbugs – stubborn bacterial infections that can evade existing treatments.

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.

Russia is developing Arctic wind turbines to supply energy to the Northern Sea Route facilities, and intends to create one of the most efficient solar power plants in the world, Mikhail Kuznetsov ...